|
|
|
Article Cited by others ORIGINAL ARTICLE
Indigenous recombinant streptokinase Vs natural streptokinase in acute myocardial infarction patients: Phase III multicentric randomized double blind trial
Diwedi S K, Hiremath J S, Kerkar P G, Reddy Krishna N, Manjunath C N, Ramesh S S, Prabhavati S, Dhobe M, Singh Kavita, Bhusari P, Rao Raman
Year : 2005| Volume: 59| Issue : 5 | Page no: 200-207 | This article has been cited by | | 1 |
Thrombolytic therapy in acute myocardial infarction |
|
| | Iyengar, S.S. | | | Indian Heart Journal. 2011; 63(1): 45-49 | | | [Pubmed] [Google Scholar] | | | 2 |
Efficacy of two streptokinase formulations in acute myocardial infarction: A double-blind randomized clinical trial |
|
| | Salarifar, M., Sadeghian, S., Abbasi, A., Davoodi, G., Amirzadegan, A., Hosseini, S.K., Paydari, N., (...), Moemeni, P. | | | Journal of Tehran University Heart Center. 2009; 4(1): 29-34 | | | [Pubmed] [Google Scholar] | | | 3 |
Streptokinase - The drug of choice for thrombolytic therapy |
|
| | Kunamneni, A., Abdelghani, T.T.A., Ellaiah, P. | | | Journal of Thrombosis and Thrombolysis. 2007; 23(1): 9-23 | | | [Pubmed] [Google Scholar] | | | 4 |
A history of streptokinase use in acute myocardial infarction |
|
| | Sikri, N., Bardia, A. | | | Texas Heart Institute Journal. 2007; 34(3): 318-327 | | | [Pubmed] [Google Scholar] | |
|
|
